New Research Poster Presentation 3.41
Pharmacokinetic Study of a Novel Extended-Release Formulation of Amphetamine Oral Disintegrating Tablet in Children Ages 6-12 with ADHD

Thursday, October 24, 2013
Jeffrey G. Stark, PhD, Worldwide Clinical Trials, Austin, TX
Russ McMahen, NEOS Therapeutics Inc., Grand Prairie, TX
Carolyn R. Sikes, PhD, NEOS Therapeutics Inc., Grand Prairie, TX
Mark Tengler, NEOS Therapeutics Inc., Grand Prairie, TX
See more of: New Research Posters Session 3
See more of: New Research Poster
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.